The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease

Pediatric Infectious Disease Journal

Volumn 27, Issue 3, 2008, Pages 207-212

  Eick, Angelia ^a,c   Karron, Ruth ^a   Shaw, Jana ^a,b   Thumar, Bhagvanji ^a   Reid, Raymond ^a   Santosham, Mathuram ^a   O'Brien, Katherine L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c Army Medical Surveillance Activity   (United States)

Author keywords

American Indians; Infants; Neutralizing antibody; Respiratory syncytial virus

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AMERICAN INDIAN; ARTICLE; CASE CONTROL STUDY; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE SEVERITY; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UMBILICAL CORD BLOOD; VIRUS INFECTION; BLOOD; FEMALE; FETUS BLOOD; HOSPITALIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; NOSE CAVITY; PROSPECTIVE STUDY; RISK FACTOR; SERODIAGNOSIS; UNITED STATES; VIROLOGY;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; HOSPITALIZATION; HUMANS; INDIANS, NORTH AMERICAN; INFANT; MALE; NASAL CAVITY; NEUTRALIZATION TESTS; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 44949236320     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31815ac585     Document Type: Article

References (20)

1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143: S127-S132.
2. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282: 1440-1446.
3. Levy BT, Graber MA. Respiratory syncytial virus infection in infants and young children. J Fam Pract. 1997;45:473-481.
4. Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis. 2001;183:16-22.
5. Holman RC, Curns AT, Cheek JE, et al. Respiratory syncytial virus hospitalizations among American Indian and Alaska native infants and the general United States infant population. Pediatrics. 2004;114:e437-e444.
6. Lowther SA, Shay DK, Holman RC, et al. Bronchiolitis-associated hospitalizations among American Indian and Alaska native children. Pediatr Infect Dis J. 2000;19:11-17.
7. Banerji A, Bell A, Mills EL, et al. Lower respiratory tract infections in Inuit infants on Baffin Island. CMAJ. 2001;164:1847-1850.
8. Liu LL, Stout JW, Sullivan M, et al. Asthma and bronchiolitis hospitalizations among American Indian children. Arch Pediatr Adolesc Med. 2000;154:991-996.
9. Bulkow LR, Singleton RJ, Karron RA, et al. Risk factors for severe respiratory syncytial virus infection among Alaska Native children. Pediatrics. 2002;109:210-216.0
10. Robin LF, Less PS, Winget M, et al. Wood-burning stoves and lower respiratory illnesses in Navajo children. Pediatr Infect Dis J. 1996;15: 859-865.1
11. Bockova J, O'Brien KL, Oski J, et al. Respiratory syncytial virus infection in Navajo and White Mountain Apache children. Pediatrics. 2002;110:e20.2
12. Ogilvie MM, Vathenen AS, Radford M, et al. Maternal antibody and respiratory syncytial virus infection in infancy. J Med Virol. 1981;7: 263-271.3
13. Piedra PA, Jewell AM, Cron SG, et al. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine. 2003;21:3479-3482.4
14. Lamprecht CL, Krause HE, Mufson MA. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis. 1976;134:211-217.5
15. Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98: 708-715.6
16. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of sevenvalent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet. 2003;362:355-361.7
17. Coates HV, Alling DW, Chanock RM. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol. 1966;83:299-313.8
18. McConnochie KM, Hall CB, Walsh EE, et al. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990;117: 52-62.9
19. Suara RO, Piedra PA, Glezen WP, et al. Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in the United States. Clin Diagn Lab Immunol. 1996;3:477-479.0
20. Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect. 2004;6:767-772.